Medicine and Dentistry
Biochemical Recurrence
16%
Cancer
16%
Cancer Surgery
9%
Cancer Therapy
8%
Chemoradiotherapy
16%
Colorectal Liver Metastasis
16%
Computer Assisted Tomography
36%
Contouring
16%
Cross-Sectional Imaging
32%
Diseases
31%
Ewing Sarcoma
16%
Female Genital System
16%
Fluorine-18
16%
Fluorodeoxyglucose F 18
39%
Guanidine
16%
Humeroscapular Periarthritis
16%
Image Quality
16%
Imaging Technique
21%
Induction Chemotherapy
9%
Laboratory Test
16%
Liver Cancer
10%
Lymph Node
8%
Lymphatic System
16%
Magnetic Resonance Imaging
100%
Mass Spectrum
16%
Mast Cell
9%
Mastocytosis
9%
Metastatic Carcinoma
32%
Morphology
8%
Multimodality Imaging
32%
Neoadjuvant Therapy
13%
Neoplasm
33%
Osteosarcoma
16%
Overall Survival
16%
Patient Care
17%
Pelvis
38%
Peripheral Nerve
16%
positron emission tomographic scan
16%
Positron Emission Tomography-Computed Tomography
57%
Prostate Cancer
16%
Prostate Specific Membrane Antigen
16%
Radiation Therapy
24%
Radiology
8%
Rectum Cancer
19%
Rectum Carcinoma
16%
Recurrent Disease
18%
Scintigraphy
16%
Side Effect
8%
Synovial Sarcoma
16%
Tumor Thrombus
16%
Keyphrases
18F-FDG PET-CT
16%
Abdominal CT
16%
Adrenal Lesions
16%
Adrenal Mass
16%
Biochemical Recurrence of Prostate Cancer
16%
Colorectal Liver Metastases
17%
Computed Tomography
13%
Cross-sectional Imaging
24%
Cystic Lesion
16%
Deep Learning Reconstruction
16%
Disease Spectrum
16%
Draining Vein
9%
Ewing Sarcoma of Bone
16%
Feature Correlation
16%
Female Genital Organs
16%
Image Features
16%
Imaging Findings
34%
Imaging Response
16%
Imaging Studies
12%
Liver Metastasis
16%
Lymphatic System
16%
Magnetic Resonance Imaging
13%
Magnetic Resonance-guided Laser Interstitial Thermal Therapy
16%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
13%
Mass Spectra
16%
Mast Cells
16%
Mastocytosis
16%
Multimodal Imaging
32%
Neoadjuvant Chemoradiotherapy (nCRT)
16%
Neoadjuvant Therapy
16%
Oncologic Imaging
16%
Overall Survival
16%
Pathological Correlation
16%
Patient Management
20%
Pelvic Osteosarcoma
16%
Peripheral Nerve
16%
Photothermal Therapy
16%
Positron Emission Tomography-computed Tomography (PET-CT)
28%
Prostate-specific Antigen
16%
Radiologists
13%
Rectal Adenocarcinoma
16%
Rectal MRI
13%
Reduced Dose
16%
Response Assessment
11%
Response Evaluation
16%
Restaging MRI
16%
Rotator Interval
10%
Synovial Sarcoma
16%
Tumor
16%
Tumor Thrombus
16%
